Ground substance

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

Retrieved on:

Martedì, Marzo 12, 2024

DEA, Research, Carbon, Ground substance, Optimism, Bright Green, Pharmaceutical industry

The proposed expansion will add 7 million square feet of manufacturing and production capabilities.

Key Points:

The proposed expansion will add 7 million square feet of manufacturing and production capabilities.
The Dalsem Agreement provides that Dalsem will construct the additional facility to its specifications and build them in a modular fashion.
Additionally, the Company has entered into a credit agreement with a lender for a $60 million senior debt financing to fund the expansion construction project (the “Credit Agreement”).
This expansion is a direct result of Bright Green obtaining the regulatory approvals for the production of Schedule I and II controlled substances from the DEA and the State of New Mexico Board of Pharmacy.

Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider

Retrieved on:

Giovedì, Marzo 14, 2024

This strategic combination unites the strengths of these entities to provide a robust, North American-based supply chain solution for both clinical and commercial APIs and drug products.

Key Points:

This strategic combination unites the strengths of these entities to provide a robust, North American-based supply chain solution for both clinical and commercial APIs and drug products.
View the full release here: https://www.businesswire.com/news/home/20240314509251/en/
The strategic combination of Noramco, Purisys, and Halo Pharma unites the strengths of these entities to provide a robust, North American-based supply chain solution for both clinical and commercial APIs and drug products.
Lee Karras, CEO of the Noramco Group, emphasized the importance of this alignment in the current market, stating, "The COVID-19 pandemic exposed critical vulnerabilities in our drug supply chain.
To explore how the Noramco Group can support API to drug product supply needs, visit www.noramco.com .

Surescripts’ Unmatched Healthcare Interoperability Delivered Intelligence Sharing at Scale in 2023

Retrieved on:

Lunedì, Marzo 11, 2024

At the same time, annual growth in PCPs using electronic prescribing averaged just 1.7% from 2019 to 2023, compared to 10% among non-PCPs.

Key Points:

At the same time, annual growth in PCPs using electronic prescribing averaged just 1.7% from 2019 to 2023, compared to 10% among non-PCPs.
“We see responsibilities shifting across the care team as other types of clinicians take on more clinical responsibility—including pharmacists, among whom e-prescribing jumped dramatically in 2023,” Harvey explained.
Together, they found and shared 1.89 billion clinical documents representing 31% of the Carequality interoperability framework’s average monthly exchange activity in 2023.
In 2023, 881,070 pharmacists, prescribers, payers and other healthcare organizations—including 22,556 pharmacies—used Clinical Direct Messaging to send and receive secure, HIPAA-compliant messages.

Analysis Group Announces Senior-Level Promotions

Retrieved on:

Giovedì, Aprile 4, 2024

BOSTON, April 4, 2024 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, announces 32 promotions to vice president across nine offices.

Key Points:

BOSTON, April 4, 2024 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, announces 32 promotions to vice president across nine offices.
"We are delighted to announce the largest group of consultant promotions to vice president in the history of our organization," said Martha S. Samuelson, CEO and Chairman of Analysis Group.
In Boston, Jonathan E. Baker specializes in the application of economic analysis to antitrust and competition, energy and environment, commercial dispute, class certification, and damages litigation matters.
Erica VanSant specializes in economic analysis of complex litigation matters in the areas of health care, antitrust, and IP.

Mothers Against Drunk Driving® (MADD) Launches The MADD Network to Address Surge in Impaired Driving Fatalities

Retrieved on:

Martedì, Aprile 2, 2024

UKG, Organization, Mother, Education, Death, Cannabis, Legal drinking age, Ground substance, Diageo, Injury, NFL, Fatality, Medical device

IRVING, Texas, April 2, 2024 /PRNewswire-PRWeb/ -- Mothers Against Drunk Driving® (MADD) is officially launching The MADD Network, a first-of-its-kind campaign that aims to unite diverse, powerhouse MADD supporters who share one vital mission- eliminating impaired driving, one of the most persistent threats to public safety on our nation's roads.

Key Points:

Rising rates of impaired driving across the country underscore the critical need for The MADD Network.
The invitation to potential allies is clear: Join the MADD Network and be part of a passionate community that wants to end impaired driving.
MADD welcomes organizations and individuals to join The MADD Network and help create a collective community impact by fighting impaired driving.
Together, the strength of the MADD Network will move to decrease impaired driving injuries and fatalities by 20% by 2026.

MedPro Systems Aligns with the Massachusetts Department of Public Health to Enhance Prescription Drug Compliance

Retrieved on:

Martedì, Marzo 26, 2024

Public health, Communication, MCSR, Acquisition, Anomaly, Ground substance, SLN, Pharmaceutical industry

MedPro Systems has taken proactive steps to assist customers in maintaining compliance with state laws.

Key Points:

MedPro Systems has taken proactive steps to assist customers in maintaining compliance with state laws.
Understanding the complex nature of Massachusetts' regulations, MedPro Systems has taken proactive steps to assist customers in maintaining compliance with state laws.
By associating Massachusetts State License Numbers (MA SLN) to Massachusetts Controlled Substance Registration (MCSR) data, MedPro is enabling essential validation fulfillment for pharmaceutical companies.
"As regulations evolve, so does the need for precise data validation and compliance strategies," said MedPro Systems CEO Greg Ungemach.

Samaritan Health Services Partners with KeyCare to Offer 24x7 Virtual Care via Epic-based Platform

Retrieved on:

Martedì, Marzo 26, 2024

Headache, Sting, Biting, Partnership, Toothache, Patient, Hospital, Constipation, Samaritan Health Services, Common, Nausea, Ground substance, Back pain, Urinary tract infection, Sprain, Fever, Allergy, Vomiting, Health

CHICAGO, March 26, 2024 /PRNewswire/ -- KeyCare, the nation's first Epic-based virtual care company, announced today that it has partnered with Samaritan Health Services to provide 24x7, national virtual urgent care services to their patients.

Key Points:

Oregon-based health system serving rural patients to offer convenient access to 24/7, on-demand virtual urgent care through MyChart
CHICAGO, March 26, 2024 /PRNewswire/ -- KeyCare , the nation's first Epic-based virtual care company, announced today that it has partnered with Samaritan Health Services to provide 24x7, national virtual urgent care services to their patients.
Samaritan patients can now obtain virtual urgent care wherever and whenever needed by conducting a virtual visit through the MyChart patient portal.
"Our partnership with KeyCare ensures that we can immediately expand access for virtual urgent care to meet our patient demand, while allowing us to add other virtual services offerings over time."
"We are thrilled to be able to help Samaritan Health Services expand access to care for its patient population, and especially fortunate to have Samaritan as our first health system partner in Oregon.

Organic Fertilizers Market worth $13.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on:

Giovedì, Marzo 21, 2024

In contrast, organic fertilizers sourced from natural origins offer a more sustainable alternative, reducing chemical runoff and environmental damage.

Key Points:

In contrast, organic fertilizers sourced from natural origins offer a more sustainable alternative, reducing chemical runoff and environmental damage.
Total organic sales, inclusive of non-food organic products, reached a record-breaking USD 67.6 billion, highlighting the growing momentum toward environmentally friendly and health-conscious consumption habits.
Plant-based organic fertilizers, sourced from materials such as compost, crop residues, seaweed, and green manure crops, are anticipated to experience the highest CAGR during the forecast period in the organic fertilizers market.
This trend is expected to persist, positioning North America as a significant contributor to the global organic fertilizers market's expansion.

Organic Fertilizers Market worth $13.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on:

Giovedì, Marzo 21, 2024

In contrast, organic fertilizers sourced from natural origins offer a more sustainable alternative, reducing chemical runoff and environmental damage.

Key Points:

In contrast, organic fertilizers sourced from natural origins offer a more sustainable alternative, reducing chemical runoff and environmental damage.
Total organic sales, inclusive of non-food organic products, reached a record-breaking USD 67.6 billion, highlighting the growing momentum toward environmentally friendly and health-conscious consumption habits.
Plant-based organic fertilizers, sourced from materials such as compost, crop residues, seaweed, and green manure crops, are anticipated to experience the highest CAGR during the forecast period in the organic fertilizers market.
This trend is expected to persist, positioning North America as a significant contributor to the global organic fertilizers market's expansion.

Pharma Source Direct, Inc. Earns NABP Drug Distributor Accreditation

Retrieved on:

Lunedì, Marzo 18, 2024

Pharmacist, Counterfeit, Doctor of Pharmacy, Pharmacy, Public, Accreditation, Active ingredient, Ground substance, NABP, API, Safety, National Association

ENGLEWOOD, Colo., March 18, 2024 /PRNewswire-PRWeb/ -- Pharma Source Direct, Inc. has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®).

Key Points:

ENGLEWOOD, Colo., March 18, 2024 /PRNewswire-PRWeb/ -- Pharma Source Direct, Inc. has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®).
"We are thrilled to announce that Pharma Source Direct, Inc. has achieved NABP Drug Distributor Accreditation," said Pharma Source President Matthew Johnson.
"We are thrilled to announce that Pharma Source Direct, Inc. has achieved NABP Drug Distributor Accreditation," said Matthew Johnson, President of Pharma Source Direct, Inc. "This prestigious recognition underscores our unwavering commitment to quality, safety, and compliance in the pharmacy compounding industry.
"NABP congratulates Pharma Source Direct, Inc. on achieving this important recognition," says NABP Executive Director/Secretary Lemrey "Al" Carter, PharmD, MS, RPh.